Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Benitec Biopharma Ltd ADR (BNTC)

Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Benitec Biopharma Ltd ADR 3940 Trust Way Hayward CA 94545 USA

www.benitec.com Employees: 19 P: 510-780-0819

Sector:

Medical

Description:

Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.

Key Statistics

Overview:

Market Capitalization, $K 372,397
Enterprise Value, $K 274,537
Shares Outstanding, K 34,354
Float, K 32,705
% Float 95.20%
Short Interest, K 2,091
Short Float 6.09%
Days to Cover 19.44
Short Volume Ratio 0.24
% of Insider Shareholders 4.80%
% of Institutional Shareholders 52.19%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -37,920 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,840 K
EBIT, $ -50,550 K
EBITDA, $ -50,480 K

Growth:

1-Year Return -11.15%
3-Year Return 127.81%
5-Year Return -79.76%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 11/14/25
Next Earnings Date 05/13/26
Earnings Per Share ttm -1.14
EPS Growth vs. Prev Qtr -18.18%
EPS Growth vs. Prev Year 27.78%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-17 on 07/26/23

BNTC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -38.92%
Return-on-Assets % -37.68%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.89
Book Value/Share 5.47
Interest Coverage -0.62
60-Month Beta 0.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar